Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages 1667-1677

  Joshu, Corinne E ^a   Prizment, Anna E ^b   Dluzniewski, Paul J ^a   Menke, Andy ^a   Folsom, Aaron R ^b,c   Coresh, Josef ^a,d   Yeh, Hsin C ^a,d   Brancati, Frederick L ^a,d   Platz, Elizabeth A ^a,e,f   Selvin, Elizabeth ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cancer incidence; cancer mortality; diabetes; glycated hemoglobin

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS;

EID: 84864450639     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27394     Document Type: Article

References (38)

1. Larsson SC, Wolk A,. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia 2011; 54: 1013-8.
2. Mitri J, Castillo J, Pittas AG,. Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 2008; 31: 2391-7.
3. Friberg E, Orsini N, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74.
4. Giovannucci E, Michaud D,. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-25.
5. Larsson SC, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121: 856-62.
6. El-Serag HB, Hampel H, Javadi F,. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-80.
7. Larsson SC, Orsini N, Brismar K, Wolk A,. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49: 2819-23.
8. Kasper JS, Giovannucci E,. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-62.
9. Tande AJ, Platz EA, Folsom AR,. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 2006; 164: 1094-102.
10. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D,. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.
11. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32 (Suppl 1): S13-61.
12. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
13. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK,. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945-52.
14. Dankner R, Chetrit A, Segal P,. Glucose tolerance status and 20 year cancer incidence. Isr Med Assoc J 2007; 9: 592-6.
15. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R,. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007; 30: 561-7.
16. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009; 6: e1000201.
17. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-41.
18. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1): S62-9.
19. Meigs JB, Nathan DM, Cupples LA, Wilson PW, Singer DE,. Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol 1996; 49: 411-7.
20. Travier N, Jeffreys M, Brewer N, Wright CS, Cunningham CW, Hornell J, Pearce N,. Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 2007; 18: 1414-9.
21. Nakanishi S, Yamada M, Hattori N, Suzuki G,. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 2005; 48: 230-4.
22. Levitan EB, Liu S, Stampfer MJ, Cook NR, Rexrode KM, Ridker PM, Buring JE, Manson JE,. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 2008; 51: 267-75.
23. Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, Marz W,. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011; 34: 1355-61.
24. Saydah S, Tao M, Imperatore G, Gregg E,. GHb level and subsequent mortality among adults in the U.S. Diabetes Care 2009; 32: 1440-6.
25. Moss SE, Klein R, Klein BE, Meuer SM,. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-9.
26. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687-702.
27. Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW,. Measurement of HbA1c from stored whole blood samples in the atherosclerosis risk in communities study. J Diabetes 2010; 2: 118-24.
28. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 (Suppl 1): S62-9.
29. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL,. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-11.
30. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G,. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 1996; 45: 699-706.
31. Atherosclerosis Risk in Communities Coordinating Center. Operations manual no. 2: cohort component procedures, version 1.0. Chapel Hill: University of North Carolina School of Public Health, 1987.
32. Vander Heiden MG, Cantley LC, Thompson CB,. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-33.
33. Pollack MN,. Insulin, insulin-like growth factors, insulin resistance, and neoplasia. Am J Clin Nutr 2007; 86: s820-2.
34. Noto H, Tsujimoto T, Sasazuki T, Noda M,. Significantly increased risk of cancer in patients with diabetes mellitus. Endocr Pract 2011; 17: 1-44.
35. Stout RL, Fulks M, Dolan VF, Magee ME, Suarez L,. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants. J Insur Med 2007; 39: 174-81.
36. Brewer N, Wright CS, Travier N, Cunningham CW, Hornell J, Pearce N, Jeffreys M,. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 2008; 31: 1144-9.
37. Carson AP, Fox CS, McGuire DK, Levitan EB, Laclaustra M, Mann DM, Muntner P,. Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes 2010; 3: 661-7.
38. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.